The Lowdown - An AI-based medical device that uniquely combines clinical guidance with real user experience to support improved contraceptive understanding and use.

The Lowdown - 一种基于人工智能的医疗设备，将临床指导与真实用户体验独特地结合起来，以支持提高避孕药具的理解和使用。

• 批准号: 10103064
• 金额: $ 48.36万
• 依托单位: GET THE LOWDOWN LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2024
• 资助国家: 英国
• 起止时间: 2024 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10103064
• 关键词: Lowdown; AI; based; medical; device

With the combined support of Innovate-UK and investment finance, Get The Lowdown Ltd (GTLD) will develop the first dedicated and clinically validated platform that combines the latest clinical guidance with real user experience to provide tailored contraceptive advice specific to the user across all forms of contraception and in doing so reducing the need for an appointment with a healthcare professional to address commonly asked questions. The concept has been designed to address key challenges in accessing support in this complex area of healthcare and known gaps in knowledge in Primary and Secondary Care with information given in an easy-to-understand format aimed at all target users regardless of ethnicity/culture, age, gender and level of health literacy. Combined grant and investor funding will accelerate development and exploitation in the global FemTech market, forecast to reach $5.0Bn by 2033 and support future application across wider health conditions including fertility, polycystic ovary syndrome and endometriosis.

借助Innovate-UK和Investment Finance的综合支持，Get Lowdown Ltd（GTLD）将开发第一个专用且经过临床验证的平台，将最新的临床指导与真正的用户体验相结合，以提供针对用户的量身定制的建议，以跨各种形式的避孕措施，从而减少对医疗保健专业人员的约会来解决常见的问题。该概念旨在应对在这一复杂的医疗保健领域获得支持的关键挑战，以及在初级和二级护理中的知识差距，并以易于理解的格式提供的信息，旨在所有目标用户，无论种族/文化，年龄，性别，性别，性别和健康素养水平如何。合并的赠款和投资者资金将加速全球FEMTECH市场的发展和开发，预测到2033年将达到50亿美元，并支持在更广泛的健康状况中的未来应用，包括生育能力，多囊卵巢综合症和子宫内膜异位症。